FGF1 supplementation ameliorates DN through anti-inflammatory and antioxidative stress mechanisms, suggesting that FGF1 is a renoprotetctive factor and therapeutic target in DN (Wei et al. 2021; Group 2020). This evidence concerns the gene FGF1 and liver dysplastic nodule.